POMC and arthritic joint disease: Conversely, overexpression of MC3R and MC3R agonist D [Trp8]-γ-MSH significantly reduced the degree of arthritis, suggesting that MC3R may be an important target in preventing bone destruction and inflammation progression in arthritis (131).